Oropouche virus (ATCC® VR-1228)

Classification: Bunyaviridae, Orthobunyavirus  /  Product Format: freeze-dried

Permits and Restrictions

View Permits

Classification Bunyaviridae, Orthobunyavirus
Agent Oropouche virus
Strain TR 9760 [V-505-001-522]
Common Name Oropouche virus
Applications
It produces severe febrile illness in man and one proven laboratory infection has occurred.
It is recommended that work with Oropouche be conducted in a facility which provides for HEPA filtration of all laboratory exhaust air.
Biosafety Level 3
Isolation
Presumed from blood from febrile patient, Trinidad, 1955
Product Format freeze-dried
Comments
Oropouche is antigenically related to Simbu virus. It produces severe febrile illness in man and one proven laboratory infection has occurred. Partially inactivated by sodium desoxycholate.
It is recommended that work with Oropouche be conducted in a facility which provides for HEPA filtration of all laboratory exhaust air.
Effect on Host
Yes, in vivo effects: causes death in host animal
Effect on Host
Yes, in vivo effects: causes death in host animal
Name of Depositor NIH/NIAID
Special Collection ATCC
Source
Presumed from blood from febrile patient, Trinidad, 1955
Year of Origin 1955
References

Spence L, et al. Oropouche virus: a new human disease agent from Trinidad, West Indies. Am. J. Trop. Med. Hyg. 10: 574-578, 1961. PubMed: 13683183

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • This item is listed on the Commerce Control List of the U.S. Department of Commerce and is distributed only within the 50 United States. Distribution requires completion of a Customer Acceptance of Responsibility (CAR) for Commerce Control List Biologicals form.
  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation